SCHEMBL14037698

SCHEMBL14037698

CCc1cnc(C(C)(C)O)n1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14012140 0.80
SCHEMBL14037751 0.74 PDE1A (0.33)
SCHEMBL14012128 0.69 SMN1; SMN2 (0.37)
SCHEMBL22494145 0.69 TSHR (0.31)
SCHEMBL27703020 0.69 ALDH1A1 (0.39)
SCHEMBL889016 0.69
SCHEMBL4037870 0.68
SCHEMBL15304172 0.67
SCHEMBL13361823 0.67
SCHEMBL12656813 0.66 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008140781-A1 SPIRO COMPOUNDS FOR TREATMENT OF INFLAMMATORY DISORDERS ATHEROGENICS, INC. (US) 2008-11-20 WO disclosed
US-20080280974-A1 Spiro compounds for treatment of inflammatory disorders CRABTREE ACQUISITION CO, LLC 2008-11-13 US disclosed